Korean Circulation Journal

  • 제48권12호
  • /
  • Pages.1145-1147
  • /
  • 2018
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

New Therapeutic Target for Pulmonary Arterial Hypertension

  • Yoon, Kyung Lim (Department of Pediatrics, Kyung Hee University Hospital at Gangdong)
  • 투고 : 2018.07.29
  • 심사 : 2018.08.07
  • 발행 : 2018.12.31
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Stenmark KR, Rabinovitch M. Emerging therapies for the treatment of pulmonary hypertension. Pediatr Crit Care Med 2010;11:S85-90. https://doi.org/10.1097/PCC.0b013e3181c76db3
  2. Marcu R, Kotha S, Zhi Z, et al. The mitochondrial permeability transition pore regulates endothelial bioenergetics and angiogenesis. Circ Res 2015;116:1336-45. https://doi.org/10.1161/CIRCRESAHA.116.304881
  3. Broughton KM, Wang BJ, Firouzi F, et al. Mechanisms of cardiac repair and regeneration. Circ Res 2018;122:1151-63. https://doi.org/10.1161/CIRCRESAHA.117.312586
  4. Yu L, Tu Y, Jia X, et al. Resveratrol protects against pulmonary arterial hypertension in rats via activation of silent Information regulator 1. Cell Physiol Biochem 2017;42:55-67. https://doi.org/10.1159/000477115
  5. Li Z, Chen S, Ma K, et al. CsA attenuates compression-induced nucleus pulposus mesenchymal stem cells apoptosis via alleviating mitochondrial dysfunction and oxidative stress. Life Sci 2018;205:26-37. https://doi.org/10.1016/j.lfs.2018.05.014
  6. Lee DS, Jung YW. Protective effect of right ventricular mitochondrial damage by cyclosporine A in monocrotaline-induced pulmonary hypertension. Korean Circ J 2018;48:1135-44. https://doi.org/10.4070/kcj.2018.0061
  7. Kim KC, Lee JC, Lee H, Cho MS, Choi SJ, Hong YM. Changes in caspase-3, B cell leukemia/lymphoma-2, interleukin-6, tumor necrosis factor-${\alpha}$ and vascular endothelial growth factor gene expression after human umbilical cord blood derived mesenchymal stem cells transfusion in pulmonary hypertension rat models. Korean Circ J 2016;46:79-92. https://doi.org/10.4070/kcj.2016.46.1.79
  8. McGee M, Whitehead N, Martin J, Collins N. Drug-associated pulmonary arterial hypertension. Clin Toxicol (Phila) 2018;6:1-9.
  9. Burks M, Stickel S, Galie N. Pulmonary arterial hypertension: combination therapy in practice. Am J Cardiovasc Drugs 2018;18:249-57. https://doi.org/10.1007/s40256-018-0272-5

피인용 문헌

  1. In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery vol.16, pp.None, 2018, https://doi.org/10.2147/ijn.s294626